Norway - 86 companies

 

 

Vetter Opens New Sales Office at Illinois Science + Technology Park in Suburban Chicago

 

In keeping with its strategy of U.S. growth and expansion, Vetter, a specialist in aseptically prefilled drug-delivery systems, today announced that it has opened a new sales office at the Illinois Science +Technology Park in Skokie. The office will be managed by Mr. Troy Carpenter, who was appointed as President of Vetter Pharma International USA Inc. rvice – is scheduled to be operational in the beginning of the fourth quarter of 2010.

 

Myconostica Announces CE Marking of MycAssay™ Product Family on Additional Platforms

 

Myconostica Ltd, the UK-based medical diagnostic company developing and commercialising rapid and highly specific tests for life-threatening fungal infections, today announces the CE marking of its lead products MycAssay™ Aspergillus and MycAssay™ Pneumocystis on the Roche Lightcycler® 2.0 and Stratagene Mx3000 series platforms.


 

   Featured companies

 
 
 

   Other Non-European countries

 
 
 
31.08.2010 Health Canada Grants Full Approval of Sativex For the Treatment of Spasticity Due to Multiple Sclerosis
GW Pharmaceuticals (AIM: GWP) and Bayer Inc., a subsidiary of Bayer AG, today announced that Health Canada has approved Sativex® [delta-9-tetrahydrocannabinol 27 mg/mL (from Tetrabinex® - cannabis sativa L. extract) and cannabidiol 25 mg/mL (from Nabidiolex® - cannabis sativa L. extract)] as adjunctive treatment for symptomatic relief of spasticity in adult patients with multiple sclerosis (MS). Sativex® is the first cannabinoid medicine derived from whole plant extracts from the cannabis sativa plant containing both delta-9-tetrahydrocannabinol and cannabidiol. This means that people in Canada with MS experiencing the debilitating symptoms of spasticity, such as painful spasms and cramps, will now have a new treatment option in addition to standard therapy. 
 
31.08.2010 Vetter Opens New Sales Office at Illinois Science + Technology Park in Suburban Chicago
In keeping with its strategy of U.S. growth and expansion, Vetter, a specialist in aseptically prefilled drug-delivery systems, today announced that it has opened a new sales office at the Illinois Science +Technology Park in Skokie. The office will be managed by Mr. Troy Carpenter, who was appointed as President of Vetter Pharma International USA Inc. The new office replaces its Yardley, Pennsylvania sales office, founded in 1983 as Vetter Pharma-Turm Inc.
 
   
 
 
  TAQXpedit PCR System (FAST End-Point)
 

FAST PCR can be achieved using FAST PCR instrumentation or by using enzyme/reagent combinations that improve PCR efficiency. With a standard thermocycler, TAQXpedite™ PCR system has been shown to achieve FAST PCR results with total reaction time as little as 16 minutes for a 500 bp amplicon (Figure 1). The TAQXpedite™ kit can be used with a FAST PCR thermocycler or a standard instrument.

   
   
   
   
   
   
   
   
 
 
 
 
 
 

Sulidin® nimesulide LPS Non-Steroidal Topical Anti-inflammatory gel for the local treatment of painful inflammatory conditions

 

Viruses against cancer

 

Particular parvoviruses normally infect rodents, but they are also infectious for human cells. However, they do not cause any disease symptoms in humans. Most importantly, these viruses have an astonishing property: They kill infected tumours cells without causing any damage to healthy tissue.

 

Smoking Causes Genetic Changes That Increase Risk of NSCLC: Presented at ASCO

 

The analysis of gene expression patterns in smokers and never-smokers has revealed smoking-related activation of genes that increase the risk of non-small-cell lung cancer (NSCLC). Knowledge of the smoking-activated genes and the affects of the proteins they encode could be exploited in targeted therapies.

 

Short people are more likely to develop heart disease than tall people

 

Short people are at greater risk of developing heart disease than tall people, according to the first systematic review and meta-analysis of all the available evidence, which is published online today (Wednesday 9 June) in the European Heart Journal [1].

 
 
 
   
   
 
 
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
 
 
   
 

                                                                

office@biotechnology-europe.com I website@biotechnology-europe.com I service@biotechnology-europe.com

 


 

Advertising Opportunities on Biotechnology Europe

Sponsorship Opportunities on Biotechnology Europe

About Biotechnology Europe

Post a Job on Biotechnology Europe

Post a Company Profile on Biotechnology Europe

Post a News on Biotechnology Europe

Post an Event on Biotechnology Europe

Post a Product on Biotechnology Europe

Post a Publication on Biotechnology Europe

Post a Technology on Biotechnology Europe

Post a Resume on Biotechnology Europe


 

Biotechnology Europe Your Partner in Bioscience and Business

  Central Internet Platform and Service Company For The Life Sciences in Europe

Imprint I Site map I Privacy Policy I Contact us I About us I Copyright BIOTECHNOLOGY WORLD  All rights reserved